Summary:
As part of a previously reported trial comparing granulocyte-colony stimulating factor (G-CSF) stimulated bone marrow and peripheral blood stem cells (PBSCs) in allogeneic stem cell transplantation, we included a questionnaire to compare donor morbidity and long-term complications between the two donation procedures. Bone marrow donation was associated with significantly more donors experiencing localized pain at the donation site compared to PBSC collection. However, this was not associated with any increased delay in returning to normal activity. Although a minority of bone marrow donors suffered chronic pain at the donation site, no serious long-term side effects relating to G-CSF stimulated stem cell donation were identified.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Isola L, Scigliano E, Skerrett D et al. A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G-CSF. Bone Marrow Transplant 1997; 20: 1033–1037.
Serody J, Sparks S, Lin Y et al. Comparison of granulocyte colony stimulating factor (G-CSF) mobilized peripheral blood progenitor cells and G-CSF stimulated bone marrow as a source of stem cells in HLA-matched sibling transplantation. Biol Blood Marrow Transplant 2000; 6: 434–440.
Morton J, Hutchins C, Durrant S . Granulocyte-colony-stimulating factor (G-CSF) primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF mobilized peripheral blood stem cells. Blood 2001; 98: 3186–3191.
Buckner C, Clift R, Sanders J et al. Marrow harvesting from normal donors. Blood 1984; 64: 630–634.
Warwick R, de Silva M, Brennan M . Care for bone marrow donors (letter). Lancet 1993; 342: 1433.
Stroncek D, Holland P, Bartch G et al. Experiences of the first 493 unrelated marrow donors in the National Marrow Donor Program. Blood 1993; 81: 1940–1946.
Andrykowski M . Psychosocial factors in bone marrow transplantation: a review and recommendations for research. Bone Marrow Transplant 1994; 13: 357–375.
Butterworth V, Simmons R, Bartsch G et al. Psychosocial effects of unrelated bone marrow donation: experiences of the National Marrow Donor Program. Blood 1993; 81: 1947–1959.
Nishimori M, Yamada Y, Hoshi K et al. Health-related quality of life of unrelated bone marrow donors in Japan. Blood 2002; 99: 1995–2001.
Bortin M, Buckner C . Major complications of marrow harvesting for transplantation. Exp Hematol 1983; 11: 916–921.
Switzer G, Dew M, Magistro C et al. The effects of bereavement on sibling bone marrow donors' psychological well-being and reactions to donation. Bone Marrow Transplant 1998; 21: 181–188.
Hill H, Chapman C, Jackson T et al. Assessment and management of donor pain following marrow harvest for allogeneic bone marrow transplantation. Bone Marrow Transplant 1989; 4: 157–161.
Switzer G, Goycoolea J, Dew M et al. Donating stimulated peripheral blood stem cells vs bone marrow: do donors experience the procedures differently? Bone Marrow Transplant 2001; 27: 917–923.
Rowley S, Donaldson G, Lilleby K et al. Experiences of donors enrolled in a randomized study of allogeneic bone marrow or peripheral blood stem cell transplantation. Blood 2001; 97: 2541–2548.
Cavallaro A, Lilleby K, Majolino I et al. Three to six year follow-up of normal donors who received recombinant human granulocyte-stimulating factor. Bone Marrow Transplant 2000; 25: 85–89.
Arcese G, Barbanti M, Biffoni F et al. Peripheral blood stem cell collection from G-CSF-stimulated unrelated donors for second transplant. Bone Marrow Transplant 1998; 22 (Suppl 5): S41–S45.
Anderlini P, Przepiorka D, Champlin R et al. Biological and clinial effects of granulocyte colony-stimulating factor in normal individuals. Blood 1996; 88: 2819–2825.
Anderlini P, Korbling M, Dale D et al. Allogeneic blood stem cell transplantation: consideration for donors. Blood 1997; 90: 903–908.
Chern B, McCarthy N, Hutchins C et al. Analgesic infiltration at the site of bone marrow harvest significantly reduces donor morbidity. Bone Marrow Transplant 1999; 23: 947–949.
Falanga A, Marchetti M, Oldani E et al. Changes of hemostatic parameters in healthy donors administered G-CSF for peripheral blood progenitor cell (PBPC) collection. Bone Marrow Transplant 1996; 17 (Suppl 2): S72.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kennedy, G., Morton, J., Western, R. et al. Impact of stem cell donation modality on normal donor quality of life: a prospective randomized study. Bone Marrow Transplant 31, 1033–1035 (2003). https://doi.org/10.1038/sj.bmt.1704053
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704053
Keywords
This article is cited by
-
Basic characteristics and safety of donation in related and unrelated haematopoietic progenitor cell donors – first 10 years of prospective donor follow-up of Swiss donors
Bone Marrow Transplantation (2022)
-
Health-related quality of life in peripheral blood stem cell donors and bone marrow donors: a prospective study in Japan
International Journal of Hematology (2020)
-
G-CSF-primed bone marrow as a source of stem cells for allografting: revisiting the concept
Bone Marrow Transplantation (2015)
-
A review of the haematopoietic stem cell donation experience: is there room for improvement?
Bone Marrow Transplantation (2014)
-
The psychosocial impact of haematopoietic SCT on sibling donors
Bone Marrow Transplantation (2012)